Source link : https://www.newshealth.biz/health-news/glp-1s-may-protect-against-progression-to-cirrhosis-in-masld/
TOPLINE: For patients with metabolic dysfunction–associated steatotic liver disease (MASLD) and diabetes, treatment with a glucagon-like peptide 1 receptor agonist (GLP-1 RA) may protect against progression to cirrhosis and mortality; however, the protective benefits do not extend to patients who already have cirrhosis, a new study found. METHODOLOGY: GLP-1 RAs reduce liver inflammation in patients […]
Author : News Health
Publish date : 2024-10-25 13:32:30
Copyright for syndicated content belongs to the linked Source.
